Logo image of VKI

INVESCO ADV MUNI INC TR II (VKI) Stock Price, Quote, News and Overview

NYSEARCA:VKI - NYSE Arca - US46132E1038 - Currency: USD

8.2  +0.01 (+0.12%)

Fundamental Rating

2

VKI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. VKI has a bad profitability rating. Also its financial health evaluation is rather negative. VKI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year VKI has reported negative net income.
VKI had a positive operating cash flow in the past year.
In multiple years VKI reported negative net income over the last 5 years.
In the past 5 years VKI always reported a positive cash flow from operatings.
VKI Yearly Net Income VS EBIT VS OCF VS FCFVKI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA -8.9%
ROE -15.16%
ROIC 2.21%
ROA(3y)-2.84%
ROA(5y)0.05%
ROE(3y)-4.84%
ROE(5y)0.02%
ROIC(3y)2.25%
ROIC(5y)2.19%
VKI Yearly ROA, ROE, ROICVKI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

In the last couple of years the Operating Margin of VKI has declined.
VKI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 61.19%
PM (TTM) N/A
GM 61.25%
OM growth 3Y-0.64%
OM growth 5Y-2.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y-2.98%
VKI Yearly Profit, Operating, Gross MarginsVKI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

More info and screens

3

2. Health

2.1 Basic Checks

VKI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, VKI has about the same amount of shares outstanding.
VKI has a better debt/assets ratio than last year.
VKI Yearly Shares OutstandingVKI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
VKI Yearly Total Debt VS Total AssetsVKI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

The Debt to FCF ratio of VKI is 3.24, which is a good value as it means it would take VKI, 3.24 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.68 indicates that VKI is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.24
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
VKI Yearly LT Debt VS Equity VS FCFVKI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.3 Liquidity

VKI has a Current Ratio of 1.70. This is a normal value and indicates that VKI is financially healthy and should not expect problems in meeting its short term obligations.
VKI has a Quick Ratio of 1.70. This is a normal value and indicates that VKI is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
VKI Yearly Current Assets VS Current LiabilitesVKI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

VKI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.51%, which is quite impressive.
The Revenue has been growing slightly by 1.50% in the past year.
VKI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.87% yearly.
EPS 1Y (TTM)99.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.76%
Revenue 1Y (TTM)1.5%
Revenue growth 3Y-3.87%
Revenue growth 5Y-4.87%
Sales Q2Q%1.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VKI Yearly Revenue VS EstimatesVKI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VKI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VKI Price Earnings VS Forward Price EarningsVKI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.15
EV/EBITDA N/A
VKI Per share dataVKI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.51%, VKI is a good candidate for dividend investing.
VKI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 7.51%

5.2 History

VKI has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of VKI decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
VKI Yearly Dividends per shareVKI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of VKI are negative and hence is the payout ratio. VKI will probably not be able to sustain this dividend level.
DP-32.07%
EPS Next 2YN/A
EPS Next 3YN/A
VKI Yearly Income VS Free CF VS DividendVKI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

More info and screens

INVESCO ADV MUNI INC TR II

NYSEARCA:VKI (7/28/2025, 8:04:00 PM)

8.2

+0.01 (+0.12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.2%
Inst Owner Change0.03%
Ins Owners0%
Ins Owner Change0%
Market Cap364.16M
Analysts45
Price TargetN/A
Short Float %0.2%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 7.51%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-32.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-17 2025-06-17 (0.0559)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.29
P/FCF 4.15
P/OCF 4.15
P/B 0.87
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.98
FCFY24.09%
OCF(TTM)1.98
OCFY24.09%
SpS0.73
BVpS9.48
TBVpS9.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.9%
ROE -15.16%
ROCE 2.8%
ROIC 2.21%
ROICexc 2.25%
ROICexgc 2.25%
OM 61.19%
PM (TTM) N/A
GM 61.25%
FCFM 272.04%
ROA(3y)-2.84%
ROA(5y)0.05%
ROE(3y)-4.84%
ROE(5y)0.02%
ROIC(3y)2.25%
ROIC(5y)2.19%
ROICexc(3y)2.27%
ROICexc(5y)2.2%
ROICexgc(3y)2.27%
ROICexgc(5y)2.2%
ROCE(3y)2.85%
ROCE(5y)2.77%
ROICexcg growth 3Y4.93%
ROICexcg growth 5Y-2.64%
ROICexc growth 3Y4.94%
ROICexc growth 5Y-2.64%
OM growth 3Y-0.64%
OM growth 5Y-2.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y-2.98%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.24
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.6
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.5%
Revenue growth 3Y-3.87%
Revenue growth 5Y-4.87%
Sales Q2Q%1.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.74%
EBIT growth 3Y-4.48%
EBIT growth 5Y-7.6%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.89%
FCF growth 3Y81.99%
FCF growth 5Y10.03%
OCF growth 1Y160.89%
OCF growth 3Y81.99%
OCF growth 5Y10.03%